Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
World Neurosurgery
|
December 13, 2017
Building Healthcare Capacity in Pediatric Neurosurgery and Psychiatry in a Post-Soviet System: Ukraine
Myroslava K Romach, James T Rutka
Neuropharmacology
|
January 24, 2023
Psychedelics: Science sabotaged by Social Media
Edward M Sellers, Myroslava K Romach
Clinical Pharmacology in Drug Development
|
October 13, 2017
Categorization of Abuse Potential-Related Adverse Events
Edward M Sellers, Myroslava K Romach
Clinical Pharmacology in Drug Development
|
January 30, 2024
Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?
Edward M Sellers, Myroslava K Romach
Neuropharmacology
|
November 23, 2017
Studies with psychedelic drugs in human volunteers
Edward M Sellers, Myroslava K Romach, Deborah B Leiderman
Neuropharmacology
|
May 6, 2014
Human abuse liability evaluation of CNS stimulant drugs
Myroslava K Romach, Kerri A Schoedel, Edward M Sellers
Journal of Opioid Management
|
February 27, 2007
Relative abuse potential of opioid formulations in Canada: a structured field study
Edward M Sellers, Reinhard Schuller, Myroslava K Romach, et al.
Psychopharmacology
|
March 10, 2004
EMD 281014, a specific and potent 5HT2 antagonist in humans: a dose-finding PET study
David Mamo, Ewen Sedman, Joachim Tillner, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
December 24, 2005
3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period
Susan E Gilbert Evans, Lori E Ross, Edward M Sellers, et al.
Journal of Clinical Psychopharmacology
|
May 15, 2002
Treatment of codeine dependence with inhibitors of cytochrome P450 2D6
Leona C Fernandes, Tansel Kilicarslan, Howard L Kaplan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
World Neurosurgery
|
December 13, 2017
Building Healthcare Capacity in Pediatric Neurosurgery and Psychiatry in a Post-Soviet System: Ukraine
Myroslava K Romach, James T Rutka
Neuropharmacology
|
January 24, 2023
Psychedelics: Science sabotaged by Social Media
Edward M Sellers, Myroslava K Romach
Clinical Pharmacology in Drug Development
|
October 13, 2017
Categorization of Abuse Potential-Related Adverse Events
Edward M Sellers, Myroslava K Romach
Clinical Pharmacology in Drug Development
|
January 30, 2024
Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?
Edward M Sellers, Myroslava K Romach
Neuropharmacology
|
November 23, 2017
Studies with psychedelic drugs in human volunteers
Edward M Sellers, Myroslava K Romach, Deborah B Leiderman
Neuropharmacology
|
May 6, 2014
Human abuse liability evaluation of CNS stimulant drugs
Myroslava K Romach, Kerri A Schoedel, Edward M Sellers
Journal of Opioid Management
|
February 27, 2007
Relative abuse potential of opioid formulations in Canada: a structured field study
Edward M Sellers, Reinhard Schuller, Myroslava K Romach, et al.
Psychopharmacology
|
March 10, 2004
EMD 281014, a specific and potent 5HT2 antagonist in humans: a dose-finding PET study
David Mamo, Ewen Sedman, Joachim Tillner, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
December 24, 2005
3alpha-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period
Susan E Gilbert Evans, Lori E Ross, Edward M Sellers, et al.
Journal of Clinical Psychopharmacology
|
May 15, 2002
Treatment of codeine dependence with inhibitors of cytochrome P450 2D6
Leona C Fernandes, Tansel Kilicarslan, Howard L Kaplan, et al.
Page
of 2